Correlation Between Asbury Automotive and Orchestra BioMed
Can any of the company-specific risk be diversified away by investing in both Asbury Automotive and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Asbury Automotive and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Asbury Automotive Group and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Asbury Automotive and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Asbury Automotive with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Asbury Automotive and Orchestra BioMed.
Diversification Opportunities for Asbury Automotive and Orchestra BioMed
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Asbury and Orchestra is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Asbury Automotive Group and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Asbury Automotive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Asbury Automotive Group are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Asbury Automotive i.e., Asbury Automotive and Orchestra BioMed go up and down completely randomly.
Pair Corralation between Asbury Automotive and Orchestra BioMed
Considering the 90-day investment horizon Asbury Automotive is expected to generate 2.33 times less return on investment than Orchestra BioMed. But when comparing it to its historical volatility, Asbury Automotive Group is 3.37 times less risky than Orchestra BioMed. It trades about 0.03 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,001 in Orchestra BioMed Holdings on October 7, 2024 and sell it today you would lose (422.00) from holding Orchestra BioMed Holdings or give up 42.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Asbury Automotive Group vs. Orchestra BioMed Holdings
Performance |
Timeline |
Asbury Automotive |
Orchestra BioMed Holdings |
Asbury Automotive and Orchestra BioMed Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Asbury Automotive and Orchestra BioMed
The main advantage of trading using opposite Asbury Automotive and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Asbury Automotive position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.Asbury Automotive vs. Sonic Automotive | Asbury Automotive vs. Lithia Motors | Asbury Automotive vs. AutoNation | Asbury Automotive vs. Penske Automotive Group |
Orchestra BioMed vs. Revelation Biosciences | Orchestra BioMed vs. Virax Biolabs Group | Orchestra BioMed vs. Neurobo Pharmaceuticals | Orchestra BioMed vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |